44206-0456 Hizentra - CanMED: NDC

Product NDC:

44206-0456

Brand Name:

Hizentra

Generic Name:

HUMAN IMMUNOGLOBULIN G

Dosage Form Name:

LIQUID

Administration Route:

Subcutaneous

Substances:

Name: HUMAN IMMUNOGLOBULIN G

Strength: 0.2

Unit: g/mL

Packages:

Code: 44206-0456-21

Description: 1 SYRINGE in 1 CARTON (44206-456-21) / 5 mL in 1 SYRINGE (44206-456-94)

Effective Date: Jan. 1, 2020

Discontinued:

Code: 44206-0456-94

Description: 1 SYRINGE in 1 CARTON (44206-456-94) > 5 mL in 1 SYRINGE (44206-456-21)

Effective Date: Jan. 1, 2020

Discontinued:

SEER*Rx Category:

Ancillary Therapy

Major Class:

Immunostimulant

Minor Class:

Human Immunoglobulin G

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox